These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Cornick J, Martens J, Martens R, Crandell R, McConnell S, Kit S. Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730 [Abstract] [Full Text] [Related]
28. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Bürki F, Rossmanith W, Nowotny N, Pallan C, Möstl K, Lussy H. Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560 [Abstract] [Full Text] [Related]
30. Epidemiology of equine herpesvirus abortion: searching for clues to the future. Gilkerson JR, Love DN, Whalley JM. Aust Vet J; 1998 Oct; 76(10):675-6. PubMed ID: 9830567 [No Abstract] [Full Text] [Related]
33. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review. Patel JR, Heldens J. Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786 [Abstract] [Full Text] [Related]
34. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse. Stokes A, Wardley RC. Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731 [Abstract] [Full Text] [Related]
35. Skin hypersensitivity to equid herpesvirus type 1 in horses. Frymus T, Woyciechowska S, Schollenberger A, Poliwoda A. Zentralbl Veterinarmed B; 1978 Jun; 25(5):431-4. PubMed ID: 211756 [No Abstract] [Full Text] [Related]
36. Equine herpesvirus 1 and 4. Reed SM, Toribio RE. Vet Clin North Am Equine Pract; 2004 Dec; 20(3):631-42. PubMed ID: 15519823 [Abstract] [Full Text] [Related]